Crosscheck

Your medical. Crosschecked.

Brain tumor

What the FAA's documents say about brain tumor, in plain words, with the FAA's own words one press away.

FAA term: Brain Tumor (Intracranial Tumor)Covers: All classes

FAA source: Brain Tumors. FAA date 29 May 2024. Checked by Crosscheck 14 October 2026

Show the FAA's words: which classes the FAA's table covers
BRAIN TUMOR (Intracranial Tumor) All Classes

FAA source: Brain Tumors. FAA date 29 May 2024. Checked by Crosscheck 14 October 2026

  • Seizures and epilepsy

    Rows A and B each note that if associated with a seizure, also refer to the Seizure section, and that an additional recovery period may apply. Crosscheck has a page on seizures and epilepsy, written from the FAA's Seizure and Epilepsy tables.
  • Acoustic neuroma

    Row A's note says that if the tumor type is acoustic neuroma or pituitary tumor, see the corresponding section. Crosscheck has a page on acoustic neuroma, written from the FAA's Acoustic Neuroma disposition table, and no page on pituitary tumor.

Short version

The disposition table has three rows.

How the FAA's table sorts Brain tumor
SituationWhat the examiner doesPathway
Row ABenign (meningioma, gliomas, etc.), NOT surgically treated
Defers to the FAA
Special Issuance
Row BBenign (meningioma, gliomas, etc.), surgically treated/resected
Defers to the FAA
Special Issuance
Row CMalignant (cancerous), primary or secondary metastatic
Defers to the FAA
Special Issuance
Show the FAA's words: the FAA's table for Brain tumor
  1. Row A · Special Issuance

    A benign brain tumor (meningioma, gliomas, etc.), NOT surgically treated. The table lists what to submit for FAA review, and the examiner defers and submits the information to the FAA for a possible Special Issuance.

    A. Benign Brain Tumor (meningioma, gliomas, etc.) NOT surgically treated … Submit the following for FAA review: … DEFER Submit the information to the FAA for a possible Special Issuance.

    FAA source: Brain Tumors. FAA date 29 May 2024. Checked by Crosscheck 14 October 2026

  2. Row B · Special Issuance

    A benign brain tumor (meningioma, gliomas, etc.), surgically treated or resected. After a two-year (2) recovery period, the table lists what to submit for FAA review, starting with all information in Row A, and the examiner defers and submits the information to the FAA for a possible Special Issuance.

    B. Benign Brain Tumor (meningioma, gliomas, etc.) Surgically treated/resected … After a two-year (2) recovery period, submit the following for FAA review: 1. All information in Row A; … DEFER Submit the information to the FAA for a possible Special Issuance.

    FAA source: Brain Tumors. FAA date 29 May 2024. Checked by Crosscheck 14 October 2026

  3. Row C · Special Issuance

    A malignant (cancerous) brain tumor, a primary tumor or a secondary metastatic tumor. After a five-year (5) recovery period following completion of chemotherapy, radiation, or surgery, the table lists what to submit for FAA review, starting with all information in Row A, and the examiner defers and submits the information to the FAA for a possible Special Issuance.

    C. Malignant (cancerous) Brain Tumor Primary Tumor or Secondary metastatic tumor … After a five-year (5) recovery period following completion of chemotherapy, radiation, or surgery. … Submit the following for FAA review: 1. All information in Row A; … DEFER Submit the information to the FAA for a possible Special Issuance.

    FAA source: Brain Tumors. FAA date 29 May 2024. Checked by Crosscheck 14 October 2026

  4. A note on the table, 1

    Row A's note says if the tumor type is acoustic neuroma or pituitary tumor, see the corresponding section.

    If tumor type is Acoustic neuroma or Pituitary Tumor - see the corresponding section.

    FAA source: Brain Tumors. FAA date 29 May 2024. Checked by Crosscheck 14 October 2026

  5. A note on the table, 2

    Rows A and B each note that if associated with a seizure, also refer to the Seizure section, and an additional recovery period may apply.

    Note: If associated with a seizure also refer to the Seizure section. An additional recovery period may apply.

    FAA source: Brain Tumors. FAA date 29 May 2024. Checked by Crosscheck 14 October 2026

What the pathway names mean

The FAA pathways for brain tumor

Which one describes yours?

The FAA's table sorts it these ways. Choose yours to see its plan.

Your step-by-step plan

  1. Step 1: The neurological evaluation

    Row A's item, which Rows B and C also ask for.Within 90 days before the exam

    A current, detailed neurological evaluation that meets FAA Specifications for Neurologic Evaluation, from a clinic visit with your treating neurologist no more than 90 days before the exam.

    Show the FAA's words: The neurological evaluation

    1. A current, detailed neurological evaluation that meets FAA Specifications for Neurologic Evaluation generated from a clinic visit with the treating neurologist no more than 90 days before the AME exam.

    FAA source: Brain Tumors. FAA date 29 May 2024; checked by Crosscheck 14 October 2026.

    2. The individual can submit the MOST RECENT detailed neurological evaluation (in lieu of one 90 days before the AME exam) that meets FAA Specifications for Neurologic Evaluation for initial case review.

    FAA source: Brain Tumors. FAA date 29 May 2024; checked by Crosscheck 14 October 2026.

  2. Step 2: The MRI of the brain

    Row A's item, which Rows B and C also ask for.

    An MRI of the brain performed no more than 12 months before the exam.

    How it is sent

    • Both the report and a copy of the images on CD in DICOM readable format, with a file name (as printed) 'DICOMDIR' in the root directory of the CD-ROM
    • The CD verified to display the images before sending
    • The table suggests keeping copies of all CDs or image (as printed), as a safeguard if lost in the mail
    Show the FAA's words: The MRI of the brain

    2. MRI brain performed no more than 12 months before the AME exam. • Submit both the report and a copy of the images on compact disc (CD) in DICOM readable format. (There MUST be a file name ‘DICOMDIR’ in the root directory of the CD-ROM). Please verify the CD will display the images before sending. You may wish to retain copies of all CDs or image as a safeguard if lost in the mail.

    FAA source: Brain Tumors. FAA date 29 May 2024; checked by Crosscheck 14 October 2026.

  3. Step 3: Hospital reports

    If hospitalized or radiation treatment was performed.

    If hospitalized or radiation treatment was performed.

    If hospitalized or radiation treatment was performed.

    If hospitalized or radiation treatment was performed: copies of these hospital reports, for each hospitalization related to this condition.

    The reports

    • Admission history and physical
    • Hospital discharge summary
    • The EMS or ambulance run sheet, if applicable
    • Hospital consultant reports, such as neurology, cardiology, internal medicine, or other specialists
    • Lab reports, including all drug or alcohol testing performed
    • Operative or procedure reports
    • Pathology reports
    • Radiology reports: the interpretive reports of all diagnostic imaging performed

    Typically not sufficient as the discharge summary

    • Not: The patient portal notes or after visit summary (AVS) that can be printed from an electronic medical record

    Do not submit

    • Not: Miscellaneous hospital records such as flowsheets, nursing notes, physician orders, and medication administration records

    Imaging

    • The interpretive report on paper and the imaging on CD in DICOM readable format, with a file named 'DICOMDIR' in the root directory of the CD-ROM
    • The CD verified to display the images before sending
    • The table suggests keeping a copy of all films, as a safeguard if lost in the mail
    Show the FAA's words: Hospital reports

    3. If hospitalized or radiation treatment was performed, submit copies of the following Hospital reports for each hospitalization related to this condition: • Admission History and Physical; • Hospital discharge summary. (Typically, the patient portal notes or after visit summary (AVS) that can be printed from an electronic medical record are NOT sufficient for pilot medical certification purposes.); • Emergency Medical Services (EMS)/ambulance run sheet (if applicable);

    • Hospital consultant report(s) (such as neurology, cardiology, internal medicine, or other specialists); • Lab report(s) including all drug or alcohol testing performed; • Operative/procedure report(s); • Pathology report(s); and • Radiology report(s). The interpretive report(s) of all diagnostic imaging (CT Scan, MRI, X-ray, ultrasound, or others) performed. Submit the interpretive report on paper and imaging on CD in DICOM readable format (there must be a file named 'DICOMDIR' in the root directory of the CD-ROM). Please verify the CD will display the images before sending. You may wish to retain a copy of all films as a safeguard if lost in the mail.

    FAA source: Brain Tumors. FAA date 29 May 2024; checked by Crosscheck 14 October 2026.

    • DO NOT submit miscellaneous hospital records such as flowsheets, nursing notes, physician orders, and medication administration records.

    FAA source: Brain Tumors. FAA date 29 May 2024; checked by Crosscheck 14 October 2026.

  4. Step 4: If the FAA asks for more

    For Rows A and C, after review of the information submitted.

    Only if required after review of the information submitted.

    Only if required after review of the information submitted.

    A neuropsychological (NP) evaluation that meets FAA Specifications for Neuropsychological Evaluation for Potential Neurocognitive Impairment.

    The table says it MAY be required after review of the information submitted.

    Show the FAA's words: If the FAA asks for more

    4. After review of the information submitted, a neuropsychological (NP) evaluation that meets FAA Specifications for Neuropsychological Evaluation for Potential Neurocognitive Impairment MAY be required.

    FAA source: Brain Tumors. FAA date 29 May 2024; checked by Crosscheck 14 October 2026.

  5. Step 5: A seizure, or an acoustic neuroma or pituitary tumor

    Where the table's notes point.

    The table's notes point to other sections of the FAA's guidance.

    The table's notes

    • Rows A and B: if associated with a seizure, also refer to the Seizure section. An additional recovery period may apply.
    • Row A: if the tumor type is acoustic neuroma or pituitary tumor, see the corresponding section
    Show the FAA's words: A seizure, or an acoustic neuroma or pituitary tumor

    Note: If associated with a seizure also refer to the Seizure section. An additional recovery period may apply.

    FAA source: Brain Tumors. FAA date 29 May 2024; checked by Crosscheck 14 October 2026.

    If tumor type is Acoustic neuroma or Pituitary Tumor - see the corresponding section.

    FAA source: Brain Tumors. FAA date 29 May 2024; checked by Crosscheck 14 October 2026.

  6. Step 6: See your AME

    The table lists what to submit for FAA review, and the examiner defers and submits the information to the FAA for a possible Special Issuance.Exam day
    • The table lists what to submit for FAA review, and the examiner defers and submits the information to the FAA for a possible Special Issuance.
    Show the FAA's words: See your AME

    A. Benign Brain Tumor (meningioma, gliomas, etc.) NOT surgically treated

    Submit the following for FAA review:

    DEFER Submit the information to the FAA for a possible Special Issuance.

    FAA source: Brain Tumors. FAA date 29 May 2024; checked by Crosscheck 14 October 2026.

What the examiner checks

It depends on which row of the FAA's table describes the case.

  • Row ADefers to the FAASpecial Issuance

    The table lists what to submit for FAA review, and the examiner defers and submits the information to the FAA for a possible Special Issuance.

    If the examiner defers
  • Row BDefers to the FAASpecial Issuance

    After a two-year (2) recovery period, the table lists what to submit for FAA review, starting with all information in Row A, and the examiner defers and submits the information to the FAA for a possible Special Issuance.

    If the examiner defers
  • Row CDefers to the FAASpecial Issuance

    After a five-year (5) recovery period following completion of chemotherapy, radiation, or surgery, the table lists what to submit for FAA review, starting with all information in Row A, and the examiner defers and submits the information to the FAA for a possible Special Issuance.

    If the examiner defers
Show the FAA's words: what the examiner does on each row
  1. Row A · Special Issuance

    A benign brain tumor (meningioma, gliomas, etc.), NOT surgically treated. The table lists what to submit for FAA review, and the examiner defers and submits the information to the FAA for a possible Special Issuance.

    A. Benign Brain Tumor (meningioma, gliomas, etc.) NOT surgically treated … Submit the following for FAA review: … DEFER Submit the information to the FAA for a possible Special Issuance.

    FAA source: Brain Tumors. FAA date 29 May 2024. Checked by Crosscheck 14 October 2026

  2. Row B · Special Issuance

    A benign brain tumor (meningioma, gliomas, etc.), surgically treated or resected. After a two-year (2) recovery period, the table lists what to submit for FAA review, starting with all information in Row A, and the examiner defers and submits the information to the FAA for a possible Special Issuance.

    B. Benign Brain Tumor (meningioma, gliomas, etc.) Surgically treated/resected … After a two-year (2) recovery period, submit the following for FAA review: 1. All information in Row A; … DEFER Submit the information to the FAA for a possible Special Issuance.

    FAA source: Brain Tumors. FAA date 29 May 2024. Checked by Crosscheck 14 October 2026

  3. Row C · Special Issuance

    A malignant (cancerous) brain tumor, a primary tumor or a secondary metastatic tumor. After a five-year (5) recovery period following completion of chemotherapy, radiation, or surgery, the table lists what to submit for FAA review, starting with all information in Row A, and the examiner defers and submits the information to the FAA for a possible Special Issuance.

    C. Malignant (cancerous) Brain Tumor Primary Tumor or Secondary metastatic tumor … After a five-year (5) recovery period following completion of chemotherapy, radiation, or surgery. … Submit the following for FAA review: 1. All information in Row A; … DEFER Submit the information to the FAA for a possible Special Issuance.

    FAA source: Brain Tumors. FAA date 29 May 2024. Checked by Crosscheck 14 October 2026

If the examiner defersSpecial Issuance

The table marks Row A, a benign brain tumor not surgically treated, DEFER.

The table marks Row B, a benign brain tumor surgically treated or resected, DEFER after a two-year (2) recovery period.

The table marks Row C, a malignant (cancerous) brain tumor, DEFER after a five-year (5) recovery period following completion of chemotherapy, radiation, or surgery.

Show the FAA's words: if the examiner defers

When the examiner defers

  1. Reason 1

    The table marks Row A, a benign brain tumor not surgically treated, DEFER.

    A. Benign Brain Tumor (meningioma, gliomas, etc.) NOT surgically treated … DEFER Submit the information to the FAA for a possible Special Issuance.

    FAA source: Brain Tumors. FAA date 29 May 2024. Checked by Crosscheck 14 October 2026

  2. Reason 2

    The table marks Row B, a benign brain tumor surgically treated or resected, DEFER after a two-year (2) recovery period.

    B. Benign Brain Tumor (meningioma, gliomas, etc.) Surgically treated/resected … After a two-year (2) recovery period, submit the following for FAA review: … DEFER Submit the information to the FAA for a possible Special Issuance.

    FAA source: Brain Tumors. FAA date 29 May 2024. Checked by Crosscheck 14 October 2026

  3. Reason 3

    The table marks Row C, a malignant (cancerous) brain tumor, DEFER after a five-year (5) recovery period following completion of chemotherapy, radiation, or surgery.

    C. Malignant (cancerous) Brain Tumor Primary Tumor or Secondary metastatic tumor … After a five-year (5) recovery period following completion of chemotherapy, radiation, or surgery. … DEFER Submit the information to the FAA for a possible Special Issuance.

    FAA source: Brain Tumors. FAA date 29 May 2024. Checked by Crosscheck 14 October 2026

What a Special Issuance is

The Guide says an Authorization for Special Issuance, valid for a specified period, may be granted at the Federal Air Surgeon's discretion to a person who does not meet the established medical standards, if the person shows to the satisfaction of the Federal Air Surgeon that the duties authorized by the class of certificate applied for can be performed without endangering public safety during the period the Authorization would be in force.

How the FAA pathways work

Good to know

Points from the FAA's own documents that are easy to miss.

  • Acoustic neuroma and pituitary tumor have their own sections

    Row A's note says if the tumor type is acoustic neuroma or pituitary tumor, see the corresponding section.

    Show the FAA's words: good to know, 1
    If tumor type is Acoustic neuroma or Pituitary Tumor - see the corresponding section.

    FAA source: Brain Tumors. FAA date 29 May 2024. Checked by Crosscheck 14 October 2026

  • For Row C, the most recent neurological evaluation

    Row C asks for all information in Row A, which includes a neurological evaluation from no more than 90 days before the exam, and its second item says the individual can submit the MOST RECENT detailed neurological evaluation in lieu of one 90 days before the exam, for initial case review.

    Show the FAA's words: good to know, 2
    1. A current, detailed neurological evaluation that meets FAA Specifications for Neurologic Evaluation generated from a clinic visit with the treating neurologist no more than 90 days before the AME exam. … 1. All information in Row A; 2. The individual can submit the MOST RECENT detailed neurological evaluation (in lieu of one 90 days before the AME exam) that meets FAA Specifications for Neurologic Evaluation for initial case review.

    FAA source: Brain Tumors. FAA date 29 May 2024. Checked by Crosscheck 14 October 2026

  • Row C's recovery period

    Row C's five-year (5) recovery period follows completion of chemotherapy, radiation, or surgery, and the row says maintenance biologic medication does not add to the above recovery time.

    Show the FAA's words: good to know, 3
    After a five-year (5) recovery period following completion of chemotherapy, radiation, or surgery. (Maintenance biologic medication does not add to the above recovery time.)

    FAA source: Brain Tumors. FAA date 29 May 2024. Checked by Crosscheck 14 October 2026

  • Row B: after surgical resection, NP testing is required

    For Row A the table says a neuropsychological (NP) evaluation MAY be required after review. For Row B, a benign tumor surgically treated or resected, it says that due to surgical resection, NP testing is required.

    Show the FAA's words: good to know, 4
    4. After review of the information submitted, a neuropsychological (NP) evaluation that meets FAA Specifications for Neuropsychological Evaluation for Potential Neurocognitive Impairment MAY be required. … (Due to surgical resection, NP testing is required.)

    FAA source: Brain Tumors. FAA date 29 May 2024. Checked by Crosscheck 14 October 2026

  • The table's closing note

    The table's closing note says a variety of intracranial tumors, both malignant and benign, are capable of causing incapacitation directly by neurologic deficit or indirectly through recurrent symptomatology, and that a history or diagnosis of an intracranial tumor necessitates a complete neurological evaluation before a determination of eligibility for medical certification can be established.

    Show the FAA's words: good to know, 5
    Note: A variety of intracranial tumors, both malignant and benign, are capable of causing incapacitation directly by neurologic deficit or indirectly through recurrent symptomatology. … A history or diagnosis of an intracranial tumor necessitates a complete neurological evaluation before a determination of eligibility for medical certification can be established.

    FAA source: Brain Tumors. FAA date 29 May 2024. Checked by Crosscheck 14 October 2026

FAA sources

Every FAA document this page relies on, with the FAA's own date and the date Crosscheck last read it. The documents to print open at the FAA, so they are always the FAA's current ones.

This reports what the FAA has published. It is not medical advice, and it does not say how the FAA or an examiner will decide a case.